Morpholino

MO3-otpb

ID
ZDB-MRPHLNO-070531-5
Name
MO3-otpb
Previous Names
None
Target
Sequence
5' - GAGCAAGTTCATTAAGTCTCACCTG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Splice-site-specific MO targeted to the second exon–intron boundary of the otpb gene.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO3-otpb
Phenotype
Phenotype resulting from MO3-otpb
Phenotype of all Fish created by or utilizing MO3-otpb
Phenotype Fish Conditions Figures
brain decreased size, abnormal WT + MO3-otpb standard conditions Fig. S6 from Ryu et al., 2007
amacrine cell decreased amount, abnormal WT + MO3-otpb standard conditions Fig. S6 from Ryu et al., 2007
dopaminergic neuron disorganized, abnormal WT + MO3-otpb standard conditions Fig. S6 from Ryu et al., 2007
caudal tuberculum dopaminergic neuron decreased amount, abnormal otpam866/m866 + MO3-otpb (AB) standard conditions Fig. 2 from Ryu et al., 2007
hypothalamus dopaminergic neuron decreased amount, abnormal otpam866/m866 + MO3-otpb (AB) standard conditions Fig. 2 from Ryu et al., 2007
postoptic commissure decreased size, abnormal otpam866/m866 + MO3-otpb (AB/TL) standard conditions Fig. 4 from Kastenhuber et al., 2010
hypothalamus dopaminergic neuron decreased amount, abnormal otpam866/m866 + MO3-otpb (AB/TL) standard conditions Fig. 4Fig. 6 from Kastenhuber et al., 2010
caudal tuberculum dopaminergic neuron absent, abnormal otpam866/m866 + MO3-otpb (AB/TL) standard conditions Fig. 4Fig. 6 from Kastenhuber et al., 2010
medial longitudinal catecholaminergic tract decreased size, abnormal otpam866/m866 + MO3-otpb (AB/TL) standard conditions Fig. 6Fig. 8 from Kastenhuber et al., 2010
medial longitudinal catecholaminergic tract absent, abnormal otpam866/m866 + MO3-otpb (AB/TL) standard conditions Fig. 4 from Kastenhuber et al., 2010
preopticohypothalamic tract absent, abnormal otpam866/m866 + MO3-otpb (AB/TL) standard conditions Fig. 4 from Kastenhuber et al., 2010
anterior catecholaminergic tract decreased size, abnormal otpam866/m866 + MO3-otpb (AB/TL) standard conditions Fig. 4Fig. 6 from Kastenhuber et al., 2010
medulla oblongata adrenergic neuron absent, abnormal otpam866/+ + MO3-otpb + MO3-tfap2a (AB/TL) standard conditions Fig. 4 from Kastenhuber et al., 2010
anterior catecholaminergic tract decreased size, abnormal otpam866/+ + MO3-otpb + MO3-tfap2a (AB/TL) standard conditions Fig. 4 from Kastenhuber et al., 2010
locus coeruleus adrenergic neuron absent, abnormal otpam866/+ + MO3-otpb + MO3-tfap2a (AB/TL) standard conditions Fig. 4 from Kastenhuber et al., 2010
anterior catecholaminergic tract absent, abnormal otpam866/m866 + MO3-otpb + MO3-tfap2a (AB/TL) standard conditions Fig. 4Fig. 7 from Kastenhuber et al., 2010
preopticohypothalamic tract absent, abnormal otpam866/m866 + MO3-otpb + MO3-tfap2a (AB/TL) standard conditions Fig. 4 from Kastenhuber et al., 2010
medial longitudinal catecholaminergic tract absent, abnormal otpam866/m866 + MO3-otpb + MO3-tfap2a (AB/TL) standard conditions Fig. 4Fig. 8 from Kastenhuber et al., 2010
diencephalon dopaminergic neuron decreased amount, abnormal otpam866/m866 + MO3-otpb + MO3-tfap2a (AB/TL) standard conditions Fig. 4 from Kastenhuber et al., 2010
locus coeruleus adrenergic neuron absent, abnormal otpam866/m866 + MO3-otpb + MO3-tfap2a (AB/TL) standard conditions Fig. 4 from Kastenhuber et al., 2010
medulla oblongata adrenergic neuron absent, abnormal otpam866/m866 + MO3-otpb + MO3-tfap2a (AB/TL) standard conditions Fig. 4 from Kastenhuber et al., 2010
postoptic commissure decreased size, abnormal otpam866/m866 + MO3-otpb + MO3-tfap2a (AB/TL) standard conditions Fig. 4 from Kastenhuber et al., 2010
Citations